Home Accuracy Inc

Accuracy Inc

New CyberKnife® S7™ System Launched by Accuracy Inc.

CyberKnife® S7™ System is built for the speed clinicians need for operational efficiency. Accurate, sub-millimetric, motion synchronized, (ultra) hypofractionated treatments can be delivered in as little as 15 minutes with Synchrony and the VOLO™ Optimizer, providing the patient throughput necessary to be successful in today's clinical environment.

Use of the Accuray TomoTherapy® System for Advanced Rectal Cancer to Improve Treatment Efficacy and Reduce Side Effects

Patients enrolled in the two studies received simultaneous daily radiation and a targeted radiation boost over a 25-day time period. The study investigators found that the TomoTherapy platform's unique architecture enabled the delivery of a high dose of radiation, directly to the tumor, through the integrated boost of radiation, while minimizing radiation to organs in close proximity to the targeted tumor.

The Urology Group Surpasses 1,600 Prostate Cancer Patients Treated with the Accuray CyberKnife® M6™ System

1/17/19: The system's unique design and advanced treatment planning software help enable physicians to avoid healthy tissue and minimize side effects on urinary, bowel, and sexual function that can reduce a man's quality of life.

Accuray CyberKnife® Customer Achieves Top Score in Multiple Brain Metastases TROG 2018 Treatment Plan Study

5/22/18: "It was a great experience to compete with all available systems for SRS treatments," said Daniela Schmitt, PhD, department of radiation oncology, Heidelberg University Hospital. "We often use the CyberKnife to treat patients with multiple brain metastases and now have confirmation of our good clinical practice. Treatment planning studies like this can help the whole community to find the best solution with their systems and to achieve the best daily clinical treatment plans based on the lessons learned."

South Florida Radiation Oncology Treats First Cancer Patients Using Its New CyberKnife® M6™ System

4/24/18: The CyberKnife platform specializes in delivering stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments with sub-millimeter precision.

Erasmus MC Completes First Step in the Evolution of Online Adaptive Radiation Therapy With the CyberKnife® System

3/27/18: New Clinical Trial Evaluates Use of Online-Adaptive Stereotactic Body Radiation Therapy Approach in the Treatment of Oligometastases

New Data Show TomoTherapy® System Superior to RapidArc in Achieving Local Control of Head and Neck Cancers

Prospective, Multicenter Study Supported by the French National Institute of Cancer Also Demonstrates that Treatment with the...

New Data Reinforce Benefits of TomoTherapy® Platform for Mainstream Radiation Therapy Treatment Indications

Accuray Incorporated (NASDAQ: ARAY) announced today that studies continue to demonstrate the unmatched flexibility of the cutting-edge...